Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

van Hooft JE, van Halsema EE, Vanbiervliet G, Beets-Tan RG, DeWitt JM, Donnellan F, Dumonceau JM, Glynne-Jones RG, Hassan C, Jiménez-Perez J, Meisner S, Muthusamy VR, Parker MC, Regimbeau JM, Sabbagh C, Sagar J, Tanis PJ, Vandervoort J, Webster GJ, Manes G, Barthet MA, Repici A.

Endoscopy. 2014 Oct 17. [Epub ahead of print] German.

PMID:
25325682
[PubMed - as supplied by publisher]
2.

Oncological outcome of malignant colonic obstruction in the Dutch Stent-In 2 trial.

Sloothaak DA, van den Berg MW, Dijkgraaf MG, Fockens P, Tanis PJ, van Hooft JE, Bemelman WA; on behalf of the collaborative Dutch Stent-In study group; on behalf of the collaborative Dutch Stent-In study group.

Br J Surg. 2014 Oct 9. doi: 10.1002/bjs.9645. [Epub ahead of print]

PMID:
25298250
[PubMed - as supplied by publisher]
3.

Long-term results of palliative stent placement for acute malignant colonic obstruction.

van den Berg MW, Ledeboer M, Dijkgraaf MG, Fockens P, Ter Borg F, van Hooft JE.

Surg Endosc. 2014 Oct 8. [Epub ahead of print]

PMID:
25294532
[PubMed - as supplied by publisher]
4.

A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia.

Walter D, van den Berg MW, van Hooft JE, Boot H, Scheffer RC, Vleggaar FP, Siersema PD.

Endoscopy. 2014 Sep 30. [Epub ahead of print]

PMID:
25268307
[PubMed - as supplied by publisher]
5.

Response:.

Lekkerkerker SJ, van der Horst A, Lens E, Fajardo RD, van Hooft JE.

Gastrointest Endosc. 2014 Sep;80(3):534. doi: 10.1016/j.gie.2014.04.027. No abstract available.

PMID:
25127953
[PubMed - in process]
6.

Biodegradable stent placement before neoadjuvant chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer.

van den Berg MW, Walter D, de Vries EM, Vleggaar FP, van Berge Henegouwen MI, van Hillegersberg R, Siersema PD, Fockens P, van Hooft JE.

Gastrointest Endosc. 2014 Jul 25. pii: S0016-5107(14)01837-9. doi: 10.1016/j.gie.2014.06.004. [Epub ahead of print] No abstract available.

PMID:
25070907
[PubMed - as supplied by publisher]
7.

Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared.

van der Horst A, Lens E, Wognum S, de Jong R, van Hooft JE, van Tienhoven G, Bel A.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):641-8. doi: 10.1016/j.ijrobp.2014.03.029. Epub 2014 May 3.

PMID:
24803041
[PubMed - indexed for MEDLINE]
8.

Differences in respiratory-induced pancreatic tumor motion between 4D treatment planning CT and daily cone beam CT, measured using intratumoral fiducials.

Lens E, van der Horst A, Kroon PS, van Hooft JE, Dávila Fajardo R, Fockens P, van Tienhoven G, Bel A.

Acta Oncol. 2014 Sep;53(9):1257-64. doi: 10.3109/0284186X.2014.905699. Epub 2014 Apr 23.

PMID:
24758251
[PubMed - in process]
9.

Bridge-to-surgery stent placement versus emergency surgery for acute malignant colonic obstruction.

van den Berg MW, Sloothaak DA, Dijkgraaf MG, van der Zaag ES, Bemelman WA, Tanis PJ, Bosker RJ, Fockens P, ter Borg F, van Hooft JE.

Br J Surg. 2014 Jun;101(7):867-73. doi: 10.1002/bjs.9521. Epub 2014 Apr 16.

PMID:
24740753
[PubMed - indexed for MEDLINE]
10.

Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.

Versteijne E, van Laarhoven HW, van Hooft JE, van Os RM, Geijsen ED, van Berge Henegouwen MI, Hulshof MC.

Dis Esophagus. 2014 Apr 11. doi: 10.1111/dote.12215. [Epub ahead of print]

PMID:
24725186
[PubMed - as supplied by publisher]
11.

Perforation in colorectal stenting: a meta-analysis and a search for risk factors.

van Halsema EE, van Hooft JE, Small AJ, Baron TH, García-Cano J, Cheon JH, Lee MS, Kwon SH, Mucci-Hennekinne S, Fockens P, Dijkgraaf MG, Repici A.

Gastrointest Endosc. 2014 Jun;79(6):970-82.e7; quiz 983.e2, 983.e5. doi: 10.1016/j.gie.2013.11.038. Epub 2014 Mar 18.

PMID:
24650852
[PubMed - in process]
12.

EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer.

Dávila Fajardo R, Lekkerkerker SJ, van der Horst A, Lens E, Bergman JJ, Fockens P, Bel A, van Hooft JE.

Gastrointest Endosc. 2014 May;79(5):851-5. doi: 10.1016/j.gie.2013.12.027. Epub 2014 Feb 8. No abstract available.

PMID:
24518121
[PubMed - in process]
13.

High proximal migration rate of a partially covered "big cup" duodenal stent in patients with malignant gastric outlet obstruction.

van den Berg MW, Walter D, Vleggaar FP, Siersema PD, Fockens P, van Hooft JE.

Endoscopy. 2014 Feb;46(2):158-61. doi: 10.1055/s-0033-1359023. Epub 2013 Dec 11.

PMID:
24338240
[PubMed - indexed for MEDLINE]
14.

Response.

van Halsema EE, van Hooft JE.

Gastrointest Endosc. 2013 Jul;78(1):192. doi: 10.1016/j.gie.2013.03.169. No abstract available.

PMID:
23820417
[PubMed - indexed for MEDLINE]
15.

Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography.

van der Horst A, Wognum S, Dávila Fajardo R, de Jong R, van Hooft JE, Fockens P, van Tienhoven G, Bel A.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):202-8. doi: 10.1016/j.ijrobp.2013.05.001. Epub 2013 Jun 19.

PMID:
23790774
[PubMed - indexed for MEDLINE]
16.

Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial.

Ahmed Ali U, Issa Y, Bruno MJ, van Goor H, van Santvoort H, Busch OR, Dejong CH, Nieuwenhuijs VB, van Eijck CH, van Dullemen HM, Fockens P, Siersema PD, Gouma DJ, van Hooft JE, Keulemans Y, Poley JW, Timmer R, Besselink MG, Vleggaar FP, Wilder-Smith OH, Gooszen HG, Dijkgraaf MG, Boermeester MA; Dutch Pancreatitis Study Group.

BMC Gastroenterol. 2013 Mar 18;13:49. doi: 10.1186/1471-230X-13-49.

PMID:
23506415
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures.

Hirdes MM, van Hooft JE, Koornstra JJ, Timmer R, Leenders M, Weersma RK, Weusten BL, van Hillegersberg R, van Berge Henegouwen MI, Plukker JT, Wiezer R, Bergman JG, Vleggaar FP, Fockens P, Siersema PD.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):795-801.e1. doi: 10.1016/j.cgh.2013.01.016. Epub 2013 Jan 30.

PMID:
23376318
[PubMed - indexed for MEDLINE]
18.

First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study.

van den Berg MW, Haijtink S, Fockens P, Vleggaar FP, Dijkgraaf MG, Siersema PD, van Hooft JE.

Endoscopy. 2013;45(3):174-81. doi: 10.1055/s-0032-1326077. Epub 2013 Jan 24.

PMID:
23348890
[PubMed - indexed for MEDLINE]
19.

Safety of endoscopic removal of self-expandable stents after treatment of benign esophageal diseases.

van Halsema EE, Wong Kee Song LM, Baron TH, Siersema PD, Vleggaar FP, Ginsberg GG, Shah PM, Fleischer DE, Ratuapli SK, Fockens P, Dijkgraaf MG, Rando G, Repici A, van Hooft JE.

Gastrointest Endosc. 2013 Jan;77(1):18-28. doi: 10.1016/j.gie.2012.09.001.

PMID:
23261092
[PubMed - indexed for MEDLINE]
20.

Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.

Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD.

Gastrointest Endosc. 2012 Aug;76(2):267-74. doi: 10.1016/j.gie.2012.04.442. Epub 2012 Jun 12.

PMID:
22695208
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk